clinical trials
Making Hepatitis C Treatment More Accessible In Malaysia
Malaysia has granted a conditional registration for an affordable hepatitis C treatment developed through public-private partnerships with organizations in Egypt and Thailand.
The Vaccine Vanguard
Vaccines are our best shot at finally overcoming the COVID-19 pandemic. Here’s a review on how vaccines work and where Asia’s leading vaccine candidates stand.
Sinovac’s CoronaVac Trials Show Favorable Results
Early clinical trials show that Sinovac’s COVID-19 vaccine candidate safely induces an immune response in healthy volunteers within a month of vaccination.
Singapore Grants ‘Conditional’ Approval For Remdesivir
Singapore's Health Sciences Authority has granted conditional approval of remdesivir as a treatment for patients with severe COVID-19.
Sinovac’s CoronaVac Shows Positive Early Results
Sinovac’s vaccine candidate for COVID-19 showed favorable immunogenicity and safety profiles in Phase I/II clinical trials.
Chinese Scientists Sequence Genome Of COVID-19
A research group in China has sequenced the genome of the COVID-19 virus and reported that the virus most likely originated from bats.
AstraZeneca’s Lung Cancer Drug Receives Regulatory Approval In China
Tagrisso, a small molecule inhibitor drug, has been approved in China as a first-line treatment for patients with non-small cell lung tumors bearing specific mutations.
Two-Pronged Approach Improves Liver Cancer Patient Outcomes
A procedure that cuts off blood supply to tumors, combined with a small molecule inhibitor drug sorafenib, improves the survival of advanced-stage liver cancer patients.
CAR-T Therapy Shows Promising Results Against Myeloma
Innovent Biologics' CT103A, a promising therapy for tough-to-treat blood cancer, has shown positive results in clinical trials.
Setting Speed Limits On Financial Reporting & Clinical Trial Disclosures
Two studies on the financial and pharmaceutical industries highlight the protective role of regulations and the human cost when companies place self-interest over compliance.
